Saliva-Based Substance Abuse Screening for the COVID-19 Era

Saliva-Based Substance Abuse Screening for the COVID-19 Era

Employees, struggling with isolation and stress from the pandemic, have increasingly turned to substance abuse. Unchecked and unmanaged, substance abuse is creating workplace performance, behavioral and morale issues. This Intelligence Brief illustrates how employers can resume substance-free workplace programs using saliva-based testing – the sample type of choice for the COVID-19 era.

Please enter your contact details to proceed.

First Name*

Last Name*

Business Email*

Phone*

Company*


By clicking download, you give consent to PreScouter to use the information you have provided to contact you about relevant content, products, and services.

We're committed to your privacy. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Saliva-Based Substance Abuse Screening for the COVID-19 Era

Evidence shows COVID-19 has been worsening America’s drug problem. In a CDC survey of US adults, 13% of respondents said in late June 2020 that they had started or increased substance use to cope with pandemic-related stress or emotions. Recent statistics suggest that 70% of Americans who use illegal drugs are employed, and that a significant percentage of this drug usage either occurs at work or employees are high when they arrive at their workplace.

Saliva-based testing is a simpler, more convenient testing approach than urine – and is also better suited to the pandemic environment. Saliva testing eliminates the need for employees to go off-site and decreases the likelihood of tampered samples. Based on decades of success with saliva-based drug testing in the insurance industry, the Federal government is actively reforming its drug testing policies to allow for more widespread saliva testing.

Included in this Intelligence Brief:

  • The importance of creating a substance-free work environment
  • How to implement a substance-free work environment
  • Why saliva is emerging as the sample of choice
  • What saliva-based testing options are available?

Since early 2020, PreScouter has expanded its capabilities to help clients deploy testing to safeguard their workplaces.
To learn more, contact us at testing@prescouter.com or ‪(708) 613-7132‬.

Never miss an insight

Get insights delivered right to your inbox

More of Our Insights & Work

Never miss an insight

Get insights delivered right to your inbox

You have successfully subscribed to our newsletter.

Too many subscribe attempts for this email address.

*